ASX up, Tesla explodes in Vegas, AUD drops
The ASX is on the up on Thursday, while Lendlease sells UK unit, Brainchip rallies again, the Aussie dollar drops and home prices slip.
News
Some mining project names are pure comedy gold
Settling on a name for a mineral deposit isn’t quite as important as naming a child but it’s clear some choose to be more creative than others, writes Kristie Batten.
Expert outlooks for markets in 2025
Donald Trump’s re-election as US president adds to uncertainty for the year ahead, according to leading analysts who have given their forecasts for global markets in 2025.
ASX miners who joined the $500m club
Gold miners were the big movers as ten ASX resources companies cleared a $500m market cap to join our Monsters of Rock club.
ASX healthcare’s 2024 winners and losers
Morgans analyst Iain Wilkie said 2024 was “pretty patchy” for the ASX healthcare sector, which underperformed broader markets.
A decent year, but ASX fizzles out for 2024
The ASX slipped again on 2024’s final day. It was still the best year since 2021 for the local bourse, however.
Resources Top 5: Speeding tickets and no news moves ring in the new year
5EA Advanced Materials has fended off a speeding ticket, while gold and Greenland explorers are among the no-news movers.
Pro Medicus notches another US contract win
A fresh $15 million deal takes radiology house Pro Medicus’s US contract wins in 2024 to at least $580 million.
Top 100 resources stocks for 2024
Numerous small caps delivered significant returns despite a tough market cycle. Here’s a collection of the top winners and gainers for 2024.
How ASX bulks performed in 2024
The ASX’s big iron ore and coal stocks let down the local market in 2024, but there were a handful of bulk winners.
ASX slips but Brainchip up 68pc in 5 days
ASX 200 drops as Santa rally fades, but energy, gold and Brainchip shine.
Gold M&A again leads the headlines
Maximus Resources has received a 7c per share takeover offer from neighbour Astral in a move that could combine the companies and their resources in the region.
Stocks fall on US debt ceiling fears
ASX falls after Wall Street sell-off, with Nvidia, Microsoft sliding and Bitcoin tumbling as traders take profits.
Telix files for key US approval
Telix CEO Chris Behrenbruch has been awarded a 68% base pay rise ahead of expected FDA approval of its kidney cancer diagnosis tool.
Gold M&A on the cards
With two juniors entering trading halts, more gold M&A could be coming in 2024. With prices near record highs, 2025 looks even wilder.
Felix sets ambitious antimony strategy
Felix Gold has laid its antimony ambitions bare, targeting 2025 restart of historic Scrafford mine in Alaska after this year’s price spike.
More small cap gems set to shine in 2025
After a stellar 2024 for recovering small to mid caps sector, our experts scour the sector for more overlooked nuggets.
Small caps poised to star in 2025
There are no dead-certs in small-cap investing, but here are some plays that just might rise and shine in 2025.
Bell Potter’s 2025 mining stocks to watch
Gold benefits from rate cuts, while copper shows long-term promise, with Bell Potter backing both for 2025.
2024’s top ASX gas performers
The gas market in 2024 offered both challenges and opportunities, here are the companies that threaded the needle and performed well.
Legally, share ownership may not be what you think
Investors should ask questions about custodial-based share arrangements by which they do not have legal ownership.
ASX up, Appen and Novonix race ahead
The ASX rallied on commodities boost on December 27. BrainChip and DroneShield led, while 2025 volatility looms with key risks.
Japan joins mission critical
The owner of a fluorspar deposit in northern WA says Japan’s Sumitomo could take a 22.5% stake in a $60m JV to develop the project.
ASX rises as Brainchip and Droneshield soar
ASX rallies on commodities, Brainchip and Droneshield soar. Meanwhile Aussies might well have spent about $1.3bn on Boxing Day.
These IPOs stole the stage in 2024
Out of 27 local IPOs in 2024, two resources plays, an engineering stock, a Mexican food chain and a wool clothing company topped the charts.
Race heads to clinic with cancer heart protection trial
Race Oncology hopes its drug candidate can protect the heart from the dangerous effect of chemotherapy.
More lithium M&As on the cards in 2025
Research firm Allens says more M&A activity is expected in 2025, confirming lithium’s positive long-term outlook.
ASX up, Avita soars, St Barbara slumps
ASX keeps the rally going on Christmas Eve as Avita jumps, St Barbara tanks. Meanwhile Bitcoin dips but ‘altcoins’ get some love.
Arcadium goes to Rio, Burley kicks iron ore goals
Arcadium shareholders approve $10 billion takeover by Rio Tinto, with the mining giant hoping to secure its lithium prize by mid-2025.
2025’s hottest resources stocks: Pt 2
In the second part of our end-of-year special, seven more fundies and analysts give their commodity and resources stock picks for 2025.
2025’s hottest resources stocks: Pt 1
In the first part of our end-of-year special, seven fundies and analysts give their commodity and resources stock picks for 2025.
3 key megatrends to shape investing
Key investment ‘megatrends’ to watch out for in 2025? Geopolitical tensions/rising defence spending, energy demand and AI growth.
Road to 2025: QMines
In this episode, host Sarah Hughan recaps the past 12 months for Queensland explorer QMines and its impressive projects.
Vanadium play QEM up on govt backing
QEM snares Coordinated Project status for its Julia Creek vanadium and oil shale project; Leeuwin shareholders like Marda gold deal.
ASX climbs closer to Christmas
Investors have seemingly been taking advantage of pre-Christmas sales, with the ASX 200 closing to the upside by a very festive 1.67%.
Road to 2025: Harvest Technology
Sarah Hughan covers Harvest Technology Group which has seen an exciting 2024 with a new CEO, a pathway to profitability and new shareholders.
ASX up 1pc as bargain hunters swoop
ASX dodges CHESS disaster, rises 1pc as bargain hunters swoop in across all sectors.
Wildcat top stock for contrarian lithium bet
Barry FitzGerald says if the consensus has gold and uranium stocks leading the way in 2025, lithium could surprise.
Bell Potter’s top tech and health stocks for 2025
Australian stockbroking and financial advisory firm Bell Potter is bullish on these tech stocks and healthcare stocks for 2025.
No Christmas break for Legacy in its tier one quest
Junior explorer Legacy Minerals believes its large landholding and tier one partners position it as having a strong chance of making a major discovery.
How to tap the $33 billion pet care market
The listed Mad Paws and Apiam Animal Health offer rare listed exposures to the lucrative and growing pet care sector.
Private credit poised for growth in 2025
Private credit is set to continue its strong growth trajectory in 2025 according to experts in the sector.
Canary Capital thinks these gold stocks could fly
Canary Capital’s Paul Hart remains bullish on gold and outlines why he’s chosen these three ASX stocks as potentially winning picks for investors.
Leeuwin surges on Marda gold deal
Leeuwin climbs after acquiring the Marda project from Ramelius, while Iltani pops up with high-grade drill results at Orient.
Gold bulls watching more than US rates
MineLife’s Gavin Wendt says gold is his key commodity pick for 2025, with analysts not just basing their bets on interest rates.
ASX hits three-month low
The local bourse hit a three-month low on Friday as CBA led the banks down, Mesoblast gave back some of its 50pc gain and the ASX had a CHESS outage.
Clean energy’s on track – can we speed it up?
Clean energy is moving ahead, believe experts, but with key tech still in diapers, hitting ultimate climate goals is no sure thing.
This biotech fell off its perch this week
Percheron fell ~90% in a week Morgans analyst Scott Power described as one of both good and bad news for the ASX healthcare sector.
Iron ore decline in Canberra crystal ball
Federal government forecasters are continuing to go bearish on iron ore prices, as Australia plans for lower bulk commodity prices.
ASX drops more as Bitcoin falls below US$97k
The ASX has taken another hit on Friday as the Fed’s cautious outlook lingers. Bitcoin has slid below US$97k and gold miners are in retreat.
Radiopharm’s first in-human study
Sarah Hughan details Radiopharm Theranostics’ first in-human study approval for the treatment of breast and gastric cancers.
Caution ahead as Fed turns hawkish
The Fed’s latest interest rate cut of 25 basis points MAY well be its last for the foreseeable future. So… now how to position as investors?
ASX silver stocks to fill your stocking
The ASX silver sector is blossoming after prices shot up almost 30% this year. Stockhead finds the pick of the bunch for your Xmas stocking.
Smart money flows to resources
Resources stocks in may have been sold off this year, but corporate activity shows majors and strategics are planning for the next boom.
ASX graphite stock calls cops on China
Novonix champions investigation into whether China is dumping graphite to force out US competitors.
Patriot recharges on VW lithium deal
Patriot, Cosmos lead gains with big developments in Canadian and Bolivian lithium, while Anax and Trek were among the no-news gainers.
ASX sinks on rate fears, Mesoblast up 52pc
The ASX hit a six-week low on a red Thursday, after the US Federal Reserve struck a more hawkish interest rates-related tone than expected.
MoneyTalks: 15 miners who can navigate choppy seas
Argonaut’s David Franklyn joins Stockhead to traverse the metals and miners he rates to overcome market turbulence.
How gas policy is letting Australia down
Australia needs more gas to offset declining supplies from ageing fields but government policy appears to getting in the way of achieving this goal.
GOT GAS: Kipper easing gas woes? Think again
The start-up of the Kipper Compression Project will keep gas flowing from the Kipper field but its impact on East Coast supplies has already been accounted for.
BlinkLab’s autism product gets global check
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the positive outcome from the US Food and Drug Administration from BlinkLab.
Fed triggers Wall Street (and ASX) sell-off
The ASX plunged nearly 2pc earlier, as a brutal Wall Street sell-off followed the Fed’s cautious outlook, signalling just two rate cuts for 2025.
Guy on Rocks: MNB
Guy Le Page looks into Minbos Resources and a phosphate opportunity to build a breadbasket in a nation which imports all of its fertiliser.
Stem-cell treatment gets breakthrough FDA approval
After years of trying, Mesoblast has won US FDA approval for its stem-cell therapies to treat the fatal graft-versus-host disease.
Volkswagen buys stake in PMT
Stockhead TV’s Sarah Hughan delves into a Volkswagen deal with Patriot Battery Metals and its North American lithium.
Brinsden’s Patriot inks major lithium deal
Volkswagen battery subsidiary PowerCo will pay C$69 million for a 9.9% stake in Canadian lithium hopeful Patriot Battery Metals.
Webull: 4 factors to boost ASX in 2025
Webull’s Talevski predicts rate cuts and US market momentum will boost the ASX in 2025, with the mining sector leading growth.
Why Copper M&A is just starting
Every major has copper at the top of its wishlist. And if you thought 2024’s M&A rush was big, just wait for what 2025 has in store.
Mali gold miners see support
Is the worst over for Mali gold miners? Bets today on ASX gold names suggest some investors may think so.
ASX slips as Fed looms
The ASX closed just into the red on Wednesday, ahead of another important Fed decision.
Rhythm hits 2024 key milestones
Predictive cancer diagnostics company Rhythm Biosciences reports it has attained all key milestones for 2024.
ASX up as MinRes seals $780m deal
ASX steadies ahead of the Fed decision. Mining leads but Percheron’s value plummets after poor trial results.
Break it Down: Pennys Find PFS
Sarah Hughan tells all on Horizon Minerals’ PFS and ore reserve for its Pennys Find project in WA’s Eastern Goldfields.
Percheron shares tumble on clinical trial failure
Percheron Therapuetic’s key trial for Duchenne muscular dystrophy has flopped, sending the shares into freefall.
The ASX resources sector looks strong in 2025
Investment manager Emanuel Datt believes Australia’s resources sector is emerging as a strong opportunity in 2025 and narrows in on three stocks.
Painchek eyes lucrative US market
Having tackled the local and UK aged-care markets, Painchek has its eyes on the much bigger US nursing home sector.
Speeding ticket can’t slow Cyclone
Cyclone Metals rose for a second straight trading day on no news, while BPM wrapped up drilling near the Mt Gibson gold mine.
ASX leaps; Novonix, Bitcoin soar
The ASX rose on Tuesday, with banks leading, while energy lagged. As for Bitcoin… its moon mission continues.
Datt forecasts US$3000/oz gold
Datt Capital founder and chief investment officer Emanuel Datt forecasts gold prices will continue to rise and may soon hit $US3000/oz.
ASX up; Bitcoin hits record on US reserve plans
The ASX opened higher on Tuesday but energy stocks weighed on the index. Meanwhile Bitcoin hit another record high amid US reserve plans.
Original URL: https://www.news.com.au/finance/business/stockhead/news/page/11